NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $104,997,000 | -3.7% | 1,242,128 | 0.0% | 0.25% | +13.6% |
Q1 2022 | $108,997,000 | +0.3% | 1,242,128 | 0.0% | 0.22% | +6.2% |
Q4 2021 | $108,649,000 | +15.3% | 1,242,128 | +7.8% | 0.21% | +4.5% |
Q3 2021 | $94,212,000 | +9.9% | 1,152,019 | +22.6% | 0.20% | +6.4% |
Q2 2021 | $85,747,000 | +7.7% | 939,794 | +0.9% | 0.19% | -3.1% |
Q1 2021 | $79,608,000 | +236.0% | 931,309 | +224.1% | 0.19% | +94.9% |
Q1 2020 | $23,690,000 | -12.9% | 287,322 | 0.0% | 0.10% | +7.6% |
Q4 2019 | $27,207,000 | +9.0% | 287,322 | 0.0% | 0.09% | +2.2% |
Q3 2019 | $24,968,000 | -4.8% | 287,322 | 0.0% | 0.09% | -9.1% |
Q2 2019 | $26,235,000 | -15.1% | 287,322 | -10.6% | 0.10% | -18.9% |
Q1 2019 | $30,890,000 | +12.0% | 321,301 | 0.0% | 0.12% | +1.7% |
Q4 2018 | $27,571,000 | -93.2% | 321,301 | -93.2% | 0.12% | -92.3% |
Q3 2018 | $408,278,000 | +14.0% | 4,738,600 | -0.1% | 1.56% | +9.3% |
Q2 2018 | $358,188,000 | -53.8% | 4,741,699 | -50.5% | 1.43% | -54.4% |
Q1 2018 | $774,532,000 | -2.4% | 9,579,868 | +1.3% | 3.13% | +0.4% |
Q4 2017 | $793,865,000 | -2.1% | 9,455,274 | +0.1% | 3.12% | -6.3% |
Q3 2017 | $811,095,000 | +21.9% | 9,447,817 | +18.5% | 3.32% | +18.5% |
Q2 2017 | $665,310,000 | +12.1% | 7,970,649 | -2.5% | 2.80% | +1.2% |
Q1 2017 | $593,720,000 | +88.9% | 8,173,974 | +89.4% | 2.77% | +78.5% |
Q4 2016 | $314,330,000 | -6.9% | 4,315,342 | +0.9% | 1.55% | -15.8% |
Q3 2016 | $337,791,000 | +17.6% | 4,278,005 | +22.9% | 1.84% | +5.4% |
Q2 2016 | $287,291,000 | +83.8% | 3,481,896 | +61.3% | 1.75% | +74.2% |
Q1 2016 | $156,338,000 | -18.9% | 2,158,172 | -3.7% | 1.00% | -22.4% |
Q4 2015 | $192,752,000 | -20.7% | 2,240,255 | -18.6% | 1.29% | -27.7% |
Q3 2015 | $243,113,000 | -6.4% | 2,751,731 | +4.2% | 1.79% | -3.6% |
Q2 2015 | $259,650,000 | -7.6% | 2,640,330 | -7.3% | 1.86% | -7.8% |
Q1 2015 | $280,927,000 | +10.8% | 2,848,871 | +4.1% | 2.01% | +5.1% |
Q4 2014 | $253,576,000 | -1.6% | 2,736,630 | -0.0% | 1.92% | -13.1% |
Q3 2014 | $257,604,000 | +4.9% | 2,736,688 | +0.9% | 2.20% | +2.4% |
Q2 2014 | $245,618,000 | +26.6% | 2,713,110 | +18.9% | 2.15% | +14.8% |
Q1 2014 | $193,989,000 | +17.4% | 2,281,683 | +11.0% | 1.87% | +11.1% |
Q4 2013 | $165,284,000 | +5.8% | 2,056,280 | +0.9% | 1.69% | -5.9% |
Q3 2013 | $156,265,000 | +8.6% | 2,037,090 | +0.1% | 1.79% | -4.9% |
Q2 2013 | $143,895,000 | – | 2,035,000 | – | 1.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |